Market Place
Sourcing Support
All News #Library
Biotech
Phage-Focused BiomX Reset May Include Defense Sector Pivot
19 Mar 2026 //
FIERCE BIOTECH
Biomx Halts Phase 2B BX004 Trial After Internal Review
08 Dec 2025 //
GLOBENEWSWIRE
Biomx Provides Update On BX004 Phase 2B Trial In Cystic Fibrosis
25 Nov 2025 //
GLOBENEWSWIRE
BiomX Updates Q3 2025 Financials & Programs
12 Nov 2025 //
GLOBENEWSWIRE
BiomX To Present Q3 2025 Financials & Program Updates On Nov
05 Nov 2025 //
GLOBENEWSWIRE
Biomx Receives FDA Support For Phage Program In Diabetic Foot
04 Nov 2025 //
GLOBENEWSWIRE
Biomx Updates Program, Reveals FDA Input To Expand BX004
17 Oct 2025 //
GLOBENEWSWIRE
BiomX’s phage therapy succeeds in Ph 2 diabetic bone study
01 Apr 2025 //
ENDPTS
BiomX to Host Q3 2024 Financial Results Call & Webcast
12 Nov 2024 //
GLOBENEWSWIRE
BiomX To Present At H.C. Wainwright Conference
04 Sep 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.